이정표 (서울대학교 의과대학, 서울특별시 보라매병원)님 | 한빛사연구자 > 한빛사

서울대학교 의과대학, 서울특별시 보라매병원

CV File

최종업데이트 2025.12.02.

Therapeutic Potential of HSP90 Inhibitor 17-DMAG in Regulating METTL3 for Kidney Fibrosis Treatment
- J. Am. Soc. Nephrol., Jan 26 2026, | https://doi.org/10.1681/ASN.0000000975
- 2026-01
- 의약학
- 한빛사논문
Differential impact of per- and polyfluoroalkyl substances exposure on hypertension risk by kidney function and metabolic status
- Environ. Int., Volume 206, December 2025 | https://doi.org/10.1016/j.envint.2025.109930
- 2025-12
- 의약학
- 한빛사논문
Exposure to Phthalates and Alternative Plasticizers in Patients with Impaired Kidney Function in Korea: Temporal Trend during 2011-2020 and Its Association with Chronic Kidney Disease
- Environ. Sci. Technol. , Oct 16 2024, | https://doi.org/10.1021/acs.est.4c03625
- 2024-10
- 의약학
- 한빛사논문
Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition
- Kidney Int., Feb 29 2024, S0085-2538(24)00163-7 | https://doi.org/10.1016/j.kint.2024.01.040
- 2024-02
- 의약학
- 한빛사논문
Targeting the m6A RNA methyltransferase METTL3 attenuates the development of kidney fibrosis
- Exp. Mol. Med., 01 February 2024 | https://doi.org/10.1038/s12276-024-01159-5
- 2024-02
- 한빛사논문
Metformin Use and Long-term Clinical Outcomes in Kidney Transplant Recipients
- Am. J. Kidney Dis., Published:March 23, 2023 | https://doi.org/10.1053/j.ajkd.2023.01.446
- 2023-03
- 의약학
- 한빛사논문
The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease
- Diabetes Care, 2020 May; 43(5): 948-955| https://doi.org/10.2337/dc19-0936
- 2020-05
- 의약학
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기